Has Philip Chen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $305,209 in general payments to Philip Chen, MD across 302 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Philip Chen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Philip Chen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Philip Chen, MD

Otolaryngology · San Antonio, TXNPI 1508069394

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $231,400 of the $305,209 with a category attached, or 75.8%. GSK accounts for 86.8% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $125,070, more than ten times the $8,005 reported in 2019. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$305,209in general payments, 2019–2025

Across 302 payments — averaging $1010.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$265K
Integra Lifesciences Corporation$12K
Medtronic$10K
Stryker$7K
Optinose US, Inc.$6K
Aerin Medical Inc.$2K
plus $3K from 9 others

$19,333in research payments, 2019–2025

Across 2 payments — averaging $9666.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Aerin Medical Inc.$19K

What the payments were for

Consulting fees$34,16411%
Speaking & faculty fees$231,40076%
Travel & lodging$27,8529%
Food & beverage$11,6714%
Education$1220%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	207	$265,026
Integra Lifesciences Corporation	12	$12,122
Medtronic(2 entities)	35	$9,707
Stryker	11	$7,468
Optinose US, Inc.	5	$5,632
Aerin Medical Inc.	13	$2,059
Amgen	2	$1,477
Inspire Medical Systems, Inc.	2	$471
Intersect ENT, Inc.	5	$447
Acclarent, Inc	4	$440
Regeneron Healthcare Solutions, Inc.	1	$138
Johnson & Johnson	2	$95
3-d Matrix, Inc.	1	$77
Sanofi	1	$26
Hologic Sales And Service, LLC	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$305,209 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas →

Medicare billing

Part B allowed, 2024

$105,743

Medicare patients

127

Services billed

454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	67	$1,567
Fluticasone Propionate	46	$678
Azelastine Hcl	22	$507
Cephalexin	23	$150
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$45
Prednisone	12	$33
Tramadol Hcl	15	$28

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Antonio

James AtkinsSan Antonio$205K
Jeffrey RosenbloomSan Antonio$23K
Jay FerrellSan Antonio$19K
Marc DeanFort Worth$486K
Amber LuongHouston$426K
Arjuna KuperanHouston$348K
Ronald KuppersmithCollege Station$325K
Ron KarniHouston$317K
Jordan RihaniSouthlake$280K
Keith MathenyFrisco$269K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →